Product Images Potassium Chloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Potassium Chloride NDC 14789-137 by Nexus Pharamaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Principal Display Panel – 10 mL Carton Label - pot0w 0004 01

Principal Display Panel – 10 mL Carton Label - pot0w 0004 01

Principal Display Panel – 10 mL Vial Label - pot0w 0004 02

Principal Display Panel – 10 mL Vial Label - pot0w 0004 02

NDC 14789-136-07 is a prescription medication that contains potassium chloride. Each milliliter (mL) of the medication contains 2 milliequivalents (mEq) or 149 milligrams (mg) of potassium chloride. The medication is a sterile, nonpyrogenic solution for injection. It has an osmolality of 4 milliosmoles per milliliter (mOsmol/m) when calculated. The usual dosage should be seen in the insert provided. Any unused portion of the concentrate should be discarded. The medication does not contain more than a certain amount (unspecified) and must be diluted with 100 milliequivalents per liter (mieg/L) before use. The medication is manufactured in the USA by NEXUS and is in a 10 mL single-dose vial. It is intended for intravenous use. The address of the manufacturer is located in Lincolnshire, IL 60069, USA.*

Principal Display Panel – 20 mL Carton Label - pot0w 0004 03

Principal Display Panel – 20 mL Carton Label - pot0w 0004 03

Principal Display Panel – 20 mL Vial Label - pot0w 0004 04

Principal Display Panel – 20 mL Vial Label - pot0w 0004 04

This text is a description for a medication labeled NDC 14789-137-07. It is recommended for prescription use only. The medication contains potassium chloride in each milliliter, specifically 2 milliequivalents or 149 milligrams. It may also contain hydrochloric acid for pH adjustment. The text emphasizes that the medication must be diluted before use. It is described as a sterile and nonpyrogenic injection concentrate, with a concentration of 4 milliosmoles per milliliter. The usual dosage is specified as 40 milliequivalents per 20 milliliters (2 milliequivalents per milliliter). The unused portion should be discarded according to the insert provided. The medication claims to contain no more than 100 micrograms per liter of aluminum. It is created in the United States by Nexus Pharmaceuticals Inc. and is packaged in a 20 mL single-dose vial. The medication is intended for intravenous use. The company's address is mentioned as Lincolnshire, IL 60069, USA.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.